Stress Urinary Incontinence (SUI) is a common problem that affects 35%-40% of women worldwide [1,2]. SUI occurs when a woman experiences involuntary leakage of urine with physical activities that increase intra-abdominal pressure such as exercise, cough, sneeze, or laugh [3]. Risk factors include age, parity, pregnancy, vaginal delivery, chronic cough, constipation, obesity, pelvic floor weakness, post-menopausal state, and prior pelvic surgery.
Minimally invasive Lumenis CO2 laser treatment offers a unique therapeutic option for women with SUI. Histologic changes are evident on basic science studies and vaginal laser treatment appears safe and well tolerated. We strongly believe that further research and future clinical studies including well designed randomized controlled trials will demonstrate the desired clinical outcomes in addition to the safety which is already a proven factor. The potential of advancing SUI treatment to a safe, minimally invasive, expeditious, durable and effective treatment option using CO2 laser therapy is an exciting area deserving further study.
